First Analysis Upgrades Repligen (RGEN) to Strong Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $179.07 -0.52%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 44
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 44
Join SI Premium – FREE
First Analysis analyst Tracy Marshbanks upgraded Repligen (NASDAQ: RGEN) from Outperform to Strong Buy with a price target of $110.00.
For an analyst ratings summary and ratings history on Repligen click here. For more ratings news on Repligen click here.
Shares of Repligen closed at $79.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Texas Instruments (TXN) to Buy
- CLSA Upgrades Mapletree Industrial Trust (MINT:SP) (MAPIF) to Outperform (2)
- Citizens Upgrades Omega Healthcare Investors (OHI) to Market Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
First AnalysisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
